Statins and the blood-brain barrier: plugging the holes.

Suppr

超能文献

作者信息

Stüve Olaf

出版信息

Ann Neurol. 2006 Jul;60(1):1-2. doi: 10.1002/ana.20914.

DOI:10.1002/ana.20914

PMID:16802301

Abstract

摘要

相似文献

Statins and the blood-brain barrier: plugging the holes.

Ann Neurol. 2006 Jul;60(1):1-2. doi: 10.1002/ana.20914.

Are "statins" beneficial or harmful in multiple sclerosis?

Neurology. 2008 Oct 28;71(18):e54-5. doi: 10.1212/01.wnl.0000335940.94945.16.

Statins to treat multiple sclerosis: friend or foe?

Neurology. 2008 Oct 28;71(18):1386-7. doi: 10.1212/01.wnl.0000327876.72639.e7.

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.

Neurology. 2008 Dec 9;71(24):2019; author reply 2019-20. doi: 10.1212/01.wnl.0000342450.63664.f5.

The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.

Autoimmunity. 2007 Mar;40(2):148-60. doi: 10.1080/08916930601183522.

Statins in multiple sclerosis: a new therapeutic option?

Mult Scler. 2003 Oct;9(5):429-30. doi: 10.1191/1352458503ms952ed.

Impact of HMG-CoA reductase inhibition on brain pathology.

Trends Pharmacol Sci. 2007 Jul;28(7):342-9. doi: 10.1016/j.tips.2007.05.001. Epub 2007 Jun 15.

Neuroinflammatory diseases and the importance of a healthy blood-brain barrier.

Curr Opin Investig Drugs. 2008 Nov;9(11):1149-50.

Statins in MS.

Int MS J. 2007 Sep;14(3):75.

The blood-brain barrier as target of multiple sclerosis research and therapy. Report of an international scientific meeting, Würzburg, January 23/24, 2004.

J Neuroimmunol. 2004 Jul;152(1-2):1-4. doi: 10.1016/j.jneuroim.2004.03.014.

引用本文的文献

An association of prior statin use with decreased perihematomal edema.

Neurocrit Care. 2008;8(1):13-8. doi: 10.1007/s12028-007-0081-1.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

相似文献

Statins and the blood-brain barrier: plugging the holes.

Ann Neurol. 2006 Jul;60(1):1-2. doi: 10.1002/ana.20914.

Are "statins" beneficial or harmful in multiple sclerosis?

Neurology. 2008 Oct 28;71(18):e54-5. doi: 10.1212/01.wnl.0000335940.94945.16.

Statins to treat multiple sclerosis: friend or foe?

Neurology. 2008 Oct 28;71(18):1386-7. doi: 10.1212/01.wnl.0000327876.72639.e7.

Statins, incident Alzheimer disease, change in cognitive function, and neuropathology.

Neurology. 2008 Dec 9;71(24):2019; author reply 2019-20. doi: 10.1212/01.wnl.0000342450.63664.f5.

The blood-brain-barrier in multiple sclerosis: functional roles and therapeutic targeting.

Autoimmunity. 2007 Mar;40(2):148-60. doi: 10.1080/08916930601183522.

Statins in multiple sclerosis: a new therapeutic option?

Mult Scler. 2003 Oct;9(5):429-30. doi: 10.1191/1352458503ms952ed.

Impact of HMG-CoA reductase inhibition on brain pathology.

Trends Pharmacol Sci. 2007 Jul;28(7):342-9. doi: 10.1016/j.tips.2007.05.001. Epub 2007 Jun 15.

Neuroinflammatory diseases and the importance of a healthy blood-brain barrier.

Curr Opin Investig Drugs. 2008 Nov;9(11):1149-50.

Statins in MS.

Int MS J. 2007 Sep;14(3):75.

The blood-brain barrier as target of multiple sclerosis research and therapy. Report of an international scientific meeting, Würzburg, January 23/24, 2004.

J Neuroimmunol. 2004 Jul;152(1-2):1-4. doi: 10.1016/j.jneuroim.2004.03.014.

引用本文的文献

An association of prior statin use with decreased perihematomal edema.

Neurocrit Care. 2008;8(1):13-8. doi: 10.1007/s12028-007-0081-1.